A woman who was diagnosed with stage 2 Hodgkin lymphoma has shared the symptoms that led to diagnosis, and discovering she had blood cancer. According to the NHS, Hodgkin Lymphoma is a "relatively ...

Researchers sought to determine whether mosunetuzumab would have long-term efficacy in patients with follicular lymphoma.

Yago Nieto, MD, PhD, discusses AFM13, how it works, and its effect as a bispecific antibody that targets CD30 and CD16.

ECHELON-3 (NCT04404283) principal investigator Craig A. Portell, MD, speaks to the significance of this triplet approval from ...

Discover the long-term results of CAR T-cell therapy, with and without stem cell transplantation, for relapsed lymphoma ...

In this phase 1 trial, patients with heavily pretreated and refractory CD30 + lymphoma were safely treated with donor-cord-blood-derived NK cells that were precomplexed with the anti-CD30 and ...

The combination of nivolumab with ipilimumab was approved for unresectable or metastatic microsatellite instability-high (MSI ...

Mesa Royalty Trust ( NYSE:MTR ) Full Year 2024 Results Key Financial Results Revenue: US$731.4k (down 78% from FY... HOUSTON, March 21, 2025--Mesa Royalty Trust (the "Trust") (NYSE: MTR ...

Let’s go Luis! Great atmosphere here at Chevy in hodgkins ! Come check them out for sure Luis Portales a very close friend of mine hooked me up!!! I was a little worry about my credit and not ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

A dealership's rating is based on all of their reviews, with more weight given to recent reviews. Includes reviews of Continental Toyota from DealerRater. Want to share your experience with this ...

Apr. 4, 2025 — A novel cell therapy approach using cord blood-derived natural killer (NK) cells pre-complexed with AFM13, or acimtamig, a CD30/CD16A bispecific antibody, was safe and generated ...